首页> 外文会议>European Meeting on Supercritical Fluids >Control of the Dissolution Rate of an Active Pharmaceutical Ingredient by Using Melt Extrusion Coupled With Supercritical CO_2
【24h】

Control of the Dissolution Rate of an Active Pharmaceutical Ingredient by Using Melt Extrusion Coupled With Supercritical CO_2

机译:用熔融挤出与超临界CO_2耦合的熔融挤出控制活性药物成分的溶出速率

获取原文

摘要

Hot-melt extrusion (HME) is a process for converting a raw material into a product of uniform shape and density by forcing it through a die under controlled conditions [1]. It represents an efficient manufacturing technology to disperse drugs in a melt up to a true molecular solution of a pharmaceutical ingredient into a polymeric matrix [2]. Most of the applications describe the preparation of solid dispersions by HME either to increase the aqueous solubility and oral bioavailability of the active substance or to control its release. The advantages of HME are: (i) avoidance of organic solvent; (ii) reduction of processing steps (one pot method); (iii) elimination of the good compressibility requirement for the active ingredients and excipients; (iv) high level of drug content uniformity; and (v) improved bioavailability through drug solubilization or molecular level dispersion in water soluble matrix [3].
机译:热熔挤出(HME)是通过在受控条件下迫使通过模具来将原料转化为均匀形状和密度的产物的方法[1]。它代表了一种有效的制造技术,用于将熔体中的药物分散到聚合物基质中的药物成分的真实分子溶液[2]。大多数应用描述了通过HME制备固体分散体,以增加活性物质的含水溶解度和口服生物利用度或控制其释放。 HME的优点是:(i)避免有机溶剂; (ii)减少处理步骤(一个罐方法); (iii)消除活性成分和赋形剂的良好压缩性要求; (iv)高水平的药物含量均匀; (v)通过水溶性基质中的药物溶解或分子水平分散体改善生物利用度[3]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号